by Shi-qi An | Feb 5, 2026 | News
Abselion’s VP of Science, Paolo Romele, has contributed to a multi-contributor editorial published by BioCompare, exploring the role of cell line selection in therapeutic antibody production. The article brings together perspectives from across the bioprocessing...
by Shi-qi An | Jan 13, 2026 | News
Ruizhi Wang, CEO and Founder of Abselion, has been included in a Technology Networks feature exploring how collaboration continues to drive innovation across the life sciences. The article gathers expert perspectives on the role of collaboration in accelerating...
by Shi-qi An | Jan 8, 2026 | News
Abselion’s CEO and Founder, Ruizhi Wang, has been featured in a multi-contributor article published by Technology Networks, sharing industry perspectives on how laboratory environments are evolving. The article brings together voices from across the life sciences to...
by Shi-qi An | Dec 15, 2025 | News
BioCompare’s 2026 outlook brings together perspectives from across the life sciences, including insights from Abselion’s Founder & CEO, Dr. Ruizhi Wang, on the evolving needs of biologics discovery and development. BioCompare has published “A Look Ahead:...
by Shi-qi An | Nov 28, 2025 | News
News-Medical publishes interview with Abselion on His-tagged protein analysisl News-Medical has published a new interview with Abselion Founder & CEO Dr Ruizhi Wang, discussing how researchers are using the Amperia™ platform to support reliable His-tagged protein...
by Shi-qi An | Oct 30, 2025 | News
Technology Networks features Abselion in discussion on advancing AAV quantification Technology Networks has published a new interview with Abselion Founder & CEO Dr Ruizhi Wang, exploring the challenges of AAV capsid quantification and the need for more...
